316 results
Page 3 of 16
6-K
EX-99.1
whj1z
7 Oct 22
Notice of Annual General Meeting
3:06pm
6-K
EX-99.2
rodgai4g5clgpp60se09
29 Aug 22
Current report (foreign)
4:00pm
6-K
EX-5.1
vu7 8aq8j6jvgyxs
19 Aug 22
Current report (foreign)
10:54am
424B5
jlaqr76ayewhuq gkdg0
19 Aug 22
Prospectus supplement for primary offering
10:52am
6-K
EX-99.1
kmab iyi5l2
1 Aug 22
Current report (foreign)
4:48pm
6-K
EX-2.1
qgrq 335b33cxugx8
19 Jul 22
Portage Biotech Acquires Outstanding Minority Interest of Invariant Natural Killer T cell (iNKT) Agonist Platform
9:01am
6-K
EX-10.3
p37hzx
8 Jul 22
Current report (foreign)
8:58am
6-K
EX-2.1
nyp9swi4grmt5
8 Jul 22
Current report (foreign)
8:58am
6-K
EX-99.1
4ksbotpmlvkimb293u88
7 Jul 22
Portage Biotech Bolsters Pipeline with Acquisition of Four Candidates Targeting the Adenosine Pathway
8:30am
20-F/A
EX-15.1
eb4gxb 9s
3 Mar 22
Annual report (foreign) (amended)
6:57pm
20-F/A
ibji4khah2m7d 8c2v5
3 Mar 22
Annual report (foreign) (amended)
6:57pm
6-K
EX-99.2
yjp2j cs3
25 Feb 22
Current report (foreign)
5:29pm
UPLOAD
s9vve8umw
17 Feb 22
Letter from SEC
12:00am
6-K
EX-99.2
q5q629
23 Nov 21
Current report (foreign)
4:30pm
6-K
EX-99.2
k3p587zceyh l1affn8k
30 Aug 21
Current report (foreign)
5:21pm